Literature DB >> 10862036

An Alu-mediated 7.1 kb deletion of BRCA1 exons 8 and 9 in breast and ovarian cancer families that results in alternative splicing of exon 10.

E M Rohlfs1, N Puget, M L Graham, B L Weber, J E Garber, C Skrzynia, J L Halperin, G M Lenoir, L M Silverman, S Mazoyer.   

Abstract

Constitutive large deletions and duplications of BRCA1 resulting from Alu-mediated recombination account for a significant proportion of disease-causing mutations in breast and/or ovarian cancer families. Using Southern blot analysis and a protein truncation test (PTT), we have identified a 7.1 kb germline deletion in two families with breast and ovarian cancer. This deletion, which includes exons 8 and 9 and leads to a frameshift at the mRNA level, appears to result from homologous recombination between closely related Alu repeats, one in intron 7 and one in intron 9. In addition to the transcript without exons 8 and 9, analysis of RNA by protein truncation test from individuals with the deletion also identified the presence of alternative splicing of exon 10 from the mutant allele, which results in a transcript that lacks exons 8, 9, and 10. Of interest is that the two American families who carry this deletion are of northern European ancestry and share a common haplotype, suggesting that this deletion may represent a founder mutation. Genes Chromosomes Cancer 28:300-307, 2000. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10862036     DOI: 10.1002/1098-2264(200007)28:3<300::aid-gcc8>3.0.co;2-1

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  15 in total

1.  The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations. The BRCA1 Exon 13 Duplication Screening Group.

Authors: 
Journal:  Am J Hum Genet       Date:  2000-05-25       Impact factor: 11.025

2.  Distinct BRCA1 rearrangements involving the BRCA1 pseudogene suggest the existence of a recombination hot spot.

Authors:  Nadine Puget; Sophie Gad; Laure Perrin-Vidoz; Olga M Sinilnikova; Dominique Stoppa-Lyonnet; Gilbert M Lenoir; Sylvie Mazoyer
Journal:  Am J Hum Genet       Date:  2002-03-05       Impact factor: 11.025

3.  The BRCA1 exon 13 duplication in the Swedish population.

Authors:  Barbara Kremeyer; Maria Soller; Kristina Lagerstedt; Paula Maguire; Sylvie Mazoyer; Margareta Nordling; Jan Wahlström; Annika Lindblom
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

4.  Increased recombination between active tRNA genes.

Authors:  Matthew J Pratt-Hyatt; Kevin M Kapadia; Thomas E Wilson; David R Engelke
Journal:  DNA Cell Biol       Date:  2006-06       Impact factor: 3.311

5.  Human genomic deletions mediated by recombination between Alu elements.

Authors:  Shurjo K Sen; Kyudong Han; Jianxin Wang; Jungnam Lee; Hui Wang; Pauline A Callinan; Matthew Dyer; Richard Cordaux; Ping Liang; Mark A Batzer
Journal:  Am J Hum Genet       Date:  2006-05-03       Impact factor: 11.025

6.  Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing.

Authors:  M A Unger; K L Nathanson; K Calzone; D Antin-Ozerkis; H A Shih; A M Martin; G M Lenoir; S Mazoyer; B L Weber
Journal:  Am J Hum Genet       Date:  2000-09-07       Impact factor: 11.025

7.  Improved survival in BRCA2 carriers with ovarian cancer.

Authors:  Tuya Pal; Jenny Permuth-Wey; Rachna Kapoor; Alan Cantor; Rebecca Sutphen
Journal:  Fam Cancer       Date:  2007       Impact factor: 2.375

8.  The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families.

Authors:  Maurizia Dalla Palma; Susan M Domchek; Jill Stopfer; Julie Erlichman; Jill D Siegfried; Jessica Tigges-Cardwell; Bernard A Mason; Timothy R Rebbeck; Katherine L Nathanson
Journal:  Cancer Res       Date:  2008-08-14       Impact factor: 12.701

9.  The deletion of exons 3-5 of BRCA1 is the first founder rearrangement identified in breast and/or ovarian cancer Spanish families.

Authors:  Sarai Palanca; Inmaculada de Juan; Gema Perez-Simó; Eva Barragán; Isabel Chirivella; Eduardo Martínez; Oscar Fuster; Pascual Bolufer
Journal:  Fam Cancer       Date:  2013-03       Impact factor: 2.375

10.  Mobile element insertions and associated structural variants in longitudinal breast cancer samples.

Authors:  Cody J Steely; Kristi L Russell; Julie E Feusier; Yi Qiao; Sean V Tavtigian; Gabor Marth; Lynn B Jorde
Journal:  Sci Rep       Date:  2021-06-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.